首页 > 最新文献

亚洲肿瘤科病例研究最新文献

英文 中文
Analysis of Clinical Characteristics of the Ma-lignant Tumor Patients Infected with 2019 Novel Coronavirus Omicron Variant 新型冠状病毒组粒变异2019型恶性肿瘤患者临床特征分析
Pub Date : 2023-01-01 DOI: 10.12677/acrpo.2023.121001
贤俊 孙
Objective: To investigate the clinical characteristics and clinical outcomes of 2019 novel corona-virus Omicron variant infected malignant tumor patients. Methods: Retrospective analysis of hospitalized patients with malignant tumors infected with 2019 novel coronavirus Omicron variant in our hospital from March 20, 2022 to May 15, 2022, according to the principle of 1:1 matching in different age groups; non malignant inpatients infected with the Omicron variant of covid-19 were randomly selected from the database, divided into malignant tumor group and non malignant tumor group. The epidemiological data, laboratory data and clinical outcomes of the two groups were compared, and the effects of different treatment schemes in the malignant tumor group on clinical outcomes were analyzed. Results: A total of 142 patients were collected, including 71 patients in the malignant tumor group and 71 patients in the non malignant tumor group. The average age of patients in the malignant tumor group was 62.89 ± 12.79 years. The main clinical symptoms were cough (36.6%), fatigue (21.1%), muscle soreness (18.3%), and fever (14.1%). According to clinical classification, 39 cases (54.9%) were mild and 18 cases (25.4%) were asymptomatic. 25.4% of the patients in the malignant tumor group had hypertension, 11.3% had coronary atherosclerotic heart disease,
{"title":"Analysis of Clinical Characteristics of the Ma-lignant Tumor Patients Infected with 2019 Novel Coronavirus Omicron Variant","authors":"贤俊 孙","doi":"10.12677/acrpo.2023.121001","DOIUrl":"https://doi.org/10.12677/acrpo.2023.121001","url":null,"abstract":"Objective: To investigate the clinical characteristics and clinical outcomes of 2019 novel corona-virus Omicron variant infected malignant tumor patients. Methods: Retrospective analysis of hospitalized patients with malignant tumors infected with 2019 novel coronavirus Omicron variant in our hospital from March 20, 2022 to May 15, 2022, according to the principle of 1:1 matching in different age groups; non malignant inpatients infected with the Omicron variant of covid-19 were randomly selected from the database, divided into malignant tumor group and non malignant tumor group. The epidemiological data, laboratory data and clinical outcomes of the two groups were compared, and the effects of different treatment schemes in the malignant tumor group on clinical outcomes were analyzed. Results: A total of 142 patients were collected, including 71 patients in the malignant tumor group and 71 patients in the non malignant tumor group. The average age of patients in the malignant tumor group was 62.89 ± 12.79 years. The main clinical symptoms were cough (36.6%), fatigue (21.1%), muscle soreness (18.3%), and fever (14.1%). According to clinical classification, 39 cases (54.9%) were mild and 18 cases (25.4%) were asymptomatic. 25.4% of the patients in the malignant tumor group had hypertension, 11.3% had coronary atherosclerotic heart disease,","PeriodicalId":66294,"journal":{"name":"亚洲肿瘤科病例研究","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66125766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of the Efficacy of Afat-inib in the Treatment of ALK-Positive Squamous Cell Carcinoma 阿法替尼治疗alk阳性鳞状细胞癌疗效分析
Pub Date : 2022-01-01 DOI: 10.12677/acrpo.2022.111001
伟 李
To explore the tumor targeted therapy for patients with ALK mutation positive lung squamous cell carcinoma and to improve the level of diagnosis and treatment. This paper reports a case of ALK
{"title":"Analysis of the Efficacy of Afat-inib in the Treatment of ALK-Positive Squamous Cell Carcinoma","authors":"伟 李","doi":"10.12677/acrpo.2022.111001","DOIUrl":"https://doi.org/10.12677/acrpo.2022.111001","url":null,"abstract":"To explore the tumor targeted therapy for patients with ALK mutation positive lung squamous cell carcinoma and to improve the level of diagnosis and treatment. This paper reports a case of ALK","PeriodicalId":66294,"journal":{"name":"亚洲肿瘤科病例研究","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66125282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of 3D Printing Template Combined with CT Guidance in Implantation and Radiotherapy of Locally Advanced Non-Small Cell Lung Cancer 3D打印模板结合CT引导在局部晚期非小细胞肺癌植入放疗中的应用
Pub Date : 2022-01-01 DOI: 10.12677/acrpo.2022.112002
平 郑
Objective: To explore the clinical application of 3D printing template combined with CT guidance in radiotherapy of interstitial implantation of non-small cell lung cancer. Methods: A retrospective study was conducted on 20 patients with lung cancer treated with radiotherapy with brachythe-rapy. In the experimental group, 10 patients used 3D printing template for short-range interstitial implantation radiotherapy. The implantation needle path was designed by the pre-planning method based on CT images, and the individual template entity and implantation needle path were created by 3D printing technology, and finally guided by CT placing the template below. The con-trol group consisted of 10 cases of doctors’ freehand implantation radiotherapy treatment plan. The freehand implantation method was not pre-planned and the direction of the implant needle was determined by the experience of the operating doctor. The differences in dosimetry and operational safety were calculated when the prescribed doses of the experimental group and the control group were 15, 30, 45 and 60 Gy, respectively. Results: The D 98 , D 95 , and D 90 of the planned target volume of the template group were higher than those of the freehand implantation method, and the difference was statistically significant (P < 0.05); The template group had lower V 5 , V 20 , V 30 , and D mean of the organ at risk lungs than the freehand implantation group (P < 0.05). The template group used a total of 83 implantation needles, the number of misses was 1 time, and there was no incident of normal tissue penetration by the implantation needle. In the unarmed group, 97 times of needle insertion were used, 4 times of missed targets, and 4 normal tissue piercing events were observed. Conclusion: The 3D printing individualized template combined with the CT guided method has dosimetry advantages over the freehand implantation method, and is easy to operate, has good repeatability, short implantation time, fewer implant needles, and the actual treatment can meet the pre-planned dose design requirements, which can improve the clinical work efficiency.
{"title":"Application of 3D Printing Template Combined with CT Guidance in Implantation and Radiotherapy of Locally Advanced Non-Small Cell Lung Cancer","authors":"平 郑","doi":"10.12677/acrpo.2022.112002","DOIUrl":"https://doi.org/10.12677/acrpo.2022.112002","url":null,"abstract":"Objective: To explore the clinical application of 3D printing template combined with CT guidance in radiotherapy of interstitial implantation of non-small cell lung cancer. Methods: A retrospective study was conducted on 20 patients with lung cancer treated with radiotherapy with brachythe-rapy. In the experimental group, 10 patients used 3D printing template for short-range interstitial implantation radiotherapy. The implantation needle path was designed by the pre-planning method based on CT images, and the individual template entity and implantation needle path were created by 3D printing technology, and finally guided by CT placing the template below. The con-trol group consisted of 10 cases of doctors’ freehand implantation radiotherapy treatment plan. The freehand implantation method was not pre-planned and the direction of the implant needle was determined by the experience of the operating doctor. The differences in dosimetry and operational safety were calculated when the prescribed doses of the experimental group and the control group were 15, 30, 45 and 60 Gy, respectively. Results: The D 98 , D 95 , and D 90 of the planned target volume of the template group were higher than those of the freehand implantation method, and the difference was statistically significant (P < 0.05); The template group had lower V 5 , V 20 , V 30 , and D mean of the organ at risk lungs than the freehand implantation group (P < 0.05). The template group used a total of 83 implantation needles, the number of misses was 1 time, and there was no incident of normal tissue penetration by the implantation needle. In the unarmed group, 97 times of needle insertion were used, 4 times of missed targets, and 4 normal tissue piercing events were observed. Conclusion: The 3D printing individualized template combined with the CT guided method has dosimetry advantages over the freehand implantation method, and is easy to operate, has good repeatability, short implantation time, fewer implant needles, and the actual treatment can meet the pre-planned dose design requirements, which can improve the clinical work efficiency.","PeriodicalId":66294,"journal":{"name":"亚洲肿瘤科病例研究","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66125746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Antituberculous Therapy on the Efficacy of Anlotinib Hydrochloride Regimens in Advanced Lung Cancer 抗结核治疗对盐酸安洛替尼治疗晚期肺癌疗效的影响
Pub Date : 2021-01-01 DOI: 10.12677/acrpo.2021.102002
磊 李
{"title":"Effect of Antituberculous Therapy on the Efficacy of Anlotinib Hydrochloride Regimens in Advanced Lung Cancer","authors":"磊 李","doi":"10.12677/acrpo.2021.102002","DOIUrl":"https://doi.org/10.12677/acrpo.2021.102002","url":null,"abstract":"","PeriodicalId":66294,"journal":{"name":"亚洲肿瘤科病例研究","volume":"155 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66125233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research Progress of TACE Combined with Sorafenib in the Treatment of HCC TACE联合索拉非尼治疗HCC的研究进展
Pub Date : 2020-01-01 DOI: 10.12677/acrpo.2020.94004
欣 姚
{"title":"Research Progress of TACE Combined with Sorafenib in the Treatment of HCC","authors":"欣 姚","doi":"10.12677/acrpo.2020.94004","DOIUrl":"https://doi.org/10.12677/acrpo.2020.94004","url":null,"abstract":"","PeriodicalId":66294,"journal":{"name":"亚洲肿瘤科病例研究","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66125675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Advances in the Study of Microsatellite Instability and Clinical and Prognosis of Gastric Cancer 胃癌微卫星不稳定性与临床及预后研究进展
Pub Date : 2019-01-22 DOI: 10.12677/acrpo.2019.81001
颖晨 史
{"title":"Advances in the Study of Microsatellite Instability and Clinical and Prognosis of Gastric Cancer","authors":"颖晨 史","doi":"10.12677/acrpo.2019.81001","DOIUrl":"https://doi.org/10.12677/acrpo.2019.81001","url":null,"abstract":"","PeriodicalId":66294,"journal":{"name":"亚洲肿瘤科病例研究","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48137315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Metastatic Malignant Melanoma Treated with Pembrolizumab Pembrolizumab治疗转移性恶性黑色素瘤1例
Pub Date : 2019-01-01 DOI: 10.12677/acrpo.2019.83004
磊 杨
{"title":"A Case of Metastatic Malignant Melanoma Treated with Pembrolizumab","authors":"磊 杨","doi":"10.12677/acrpo.2019.83004","DOIUrl":"https://doi.org/10.12677/acrpo.2019.83004","url":null,"abstract":"","PeriodicalId":66294,"journal":{"name":"亚洲肿瘤科病例研究","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66125603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Application of ERAS Received 3D Printing (PEEK Material) in 1 Case of Sternal Osteosarcoma with Individualized Nursing in Patients with Thoracic and Rib Reconstruction 3D打印(PEEK材料)ERAS在胸骨骨肉瘤中的应用及胸肋重建患者的个体化护理
Pub Date : 2019-01-01 DOI: 10.12677/acrpo.2019.81002
虹 路
{"title":"The Application of ERAS Received 3D Printing (PEEK Material) in 1 Case of Sternal Osteosarcoma with Individualized Nursing in Patients with Thoracic and Rib Reconstruction","authors":"虹 路","doi":"10.12677/acrpo.2019.81002","DOIUrl":"https://doi.org/10.12677/acrpo.2019.81002","url":null,"abstract":"","PeriodicalId":66294,"journal":{"name":"亚洲肿瘤科病例研究","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66125537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adult Solid Alveolar Rhabdomyosarcoma: A Case Report and Literature Review 成人实性肺泡横纹肌肉瘤1例报告及文献复习
Pub Date : 2019-01-01 DOI: 10.12677/acrpo.2019.82003
洁 彭
{"title":"Adult Solid Alveolar Rhabdomyosarcoma: A Case Report and Literature Review","authors":"洁 彭","doi":"10.12677/acrpo.2019.82003","DOIUrl":"https://doi.org/10.12677/acrpo.2019.82003","url":null,"abstract":"","PeriodicalId":66294,"journal":{"name":"亚洲肿瘤科病例研究","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66125587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case Report of Using Salvage Boron Neutron Capture Therapy (BNCT) to Improve a Recurrent Hypopharyngeal Cancer Patient 补救性硼中子俘获治疗复发性下咽癌1例报告
Pub Date : 2019-01-01 DOI: 10.12677/acrpo.2019.84005
一玮 陈
{"title":"A Case Report of Using Salvage Boron Neutron Capture Therapy (BNCT) to Improve a Recurrent Hypopharyngeal Cancer Patient","authors":"一玮 陈","doi":"10.12677/acrpo.2019.84005","DOIUrl":"https://doi.org/10.12677/acrpo.2019.84005","url":null,"abstract":"","PeriodicalId":66294,"journal":{"name":"亚洲肿瘤科病例研究","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66125654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
亚洲肿瘤科病例研究
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1